Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys

Psychopharmacology

Volumn 147, Issue 1, 1999, Pages 73-80

  Butelman, Eduardo R ^a   Harris, Todd J ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

opioid receptor; Dynorphin; E 2078; Macaca mulatta; Naltrexone; Prolactin; Sedation

Indexed keywords

3 [1 (3,4 DICHLORO N METHYLPHENYLACETAMIDO) 2 (1 PYRROLIDINYL)ETHYL]PHENOXYACETIC ACID; DYNORPHIN A [1-8][1 (N METHYLTYROSINE) 7 (N METHYLARGININE) 8 DEXTRO LEUCINE N ETHYLAMIDE]; NALTREXONE; PROLACTIN; QUADAZOCINE; SPIRADOLINE;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG STABILITY; FEMALE; MALE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RHESUS MONKEY; SCORING SYSTEM; SEDATION;

ANIMALS; AZOCINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; FEMALE; HYPNOTICS AND SEDATIVES; INJECTIONS, SUBCUTANEOUS; MACACA MULATTA; MALE; MOTOR ACTIVITY; MUSCLE RELAXATION; NALTREXONE; NARCOTIC ANTAGONISTS; PEPTIDE FRAGMENTS; PROLACTIN; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; TIME FACTORS;

EID: 0033988331     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051144     Document Type: Article

References (39)

1. Bero LA, Lurie SN, Kuhn CM (1987) Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat. Brain Res 465:189-196
2. Blackford SP, Little P, Kuhn CM (1992) Mu- and kappa- opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin. Endocrinology 131:2891-2897
3. Butelman ER, Ko MC, Sobczyk-Kojiro K, Mosberg HI, VanBemmel B, Zernig G, Woods JH (1998) Kappa-opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. J Pharmacol Exp Ther 285:595-601
4. Butelman ER, Harris TJ, Perez A and Kreek MJ (1999a) Effects of systemically administered dynorphin A(1-17) in rhesus monkeys. J Pharmacol Exp Ther 290:678-686
5. Butelman ER, Vivian JA, Yu J, Kreek MJ, Woods JH (1999b) Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys. Psychopharmacology 143:190-196
6. Dykstra LA, Woods JH (1986) A tail withdrawal procedure for assessment of analgesic activity in rhesus monkeys. J Pharmacol Methods 15:263-269
7. Dykstra LA, Gmerek DE, Winger G, Woods JH (1987a) Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia, and discriminative stimulus effects. J Pharmacol Exp Ther 242:413-420
8. Dykstra LA, Gmerek DE, Winger GD, Woods JH (1987b) Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine. J Pharmacol Exp Ther 242:421-427
9. France CP, Morse WH (1989) Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys. J Pharmacol Exp Ther 250:928-936
10. France CP, Medzihradsky F, Woods JH (1994) Comparison of kappa opioids in rhesus monkeys: behavioral effects and binding affinities. J Pharmacol Exp Ther 268:47-58
11. Gerak LR, Butelman ER, Woods JH, France CP (1994) Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 271:993-999
12. Giardina G, Clarke GD, Grugni M, Sbacchi M, Vecchietti V (1995) Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes. Farmaco 50:405-418
13. Gilbeau PM, Hosobuchi Y, Lee NM (1986) Dynorphin effects on plasma concentrations of anterior pituitary hormones in the nonhuman primate. J Pharmacol Exp Ther 238:974-977
14. Goodman RR, Snyder SH (1982) Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects. Proc Natl Acad Sci USA 79:5703-5707
15. Kapusta DR (1995) Opioid mechanisms controlling renal function. Clin Exp Pharmacol Physiol 22:891-202
16. 2 analysis in rhesus monkeys. J Pharmacol Exp Ther 285:518-526
17. Leander JD, Hart JC, Zerbe RL (1987) Kappa-agonist induced diuresis:evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. J Pharmacol Exp Ther 242:33-39
18. Lewis ME, Khachaturian H, Akil H, Watson SJ (1984) Anatomical relationship between opioid peptides and receptors in rhesus monkey brain. Brain Res Bull 13:801-812
19. Locke KW, Brown DR, Holtzman SG (1982) Effects of opiate antagonists and putative mu- and kappa- agonists on milk intake in rat and squirrel monkey. Pharmacol Biochem Behav 17:1275-1279
20. Merchenthaler I (1991) Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold. Neuroscience 44:655-662
21. Moore KE, Lookingland KJ (1995) Dopaminergic neuronal systems in the hypothalamus. In: Bloom FE, Kupfer DE (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 245-256
22. Murahashi N, Kato A, Koyama N, Watanabe S, Yuzuriha T, Miyake Y (1989) Rectal absorption of E-2078 (dynorphin analogue peptide) in rats. J Pharm Pharmacol 41:770-774
23. Nakazawa T, Furuya Y, Kaneko T, Yamatsu K, Yoshino H, Tachibana S (1990) Analgesia produced by E-2078, a systemically active dynorphin analog in mice. J Pharmacol Exp Ther 252:1247-1254
24. Nakazawa T, Furuya Y, Kaneko T, Yamatsu K (1991) Spinal kappa-receptor mediated analgesia of E-2078, a systemically active dynorphin analog, in mice. J Pharmacol Exp Ther 256:76-81
25. Negus SS, Burke TF, Medzhiradsky F, Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267:896-903
26. Negus SS, Gatch MB, Mello NK, Zhang X, Rice K (1998) Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286:362-375
27. Ohnishi A, Mihara M, Yasuda S, Tomono Y, Hasegawa J, Tanaka J (1994) Aquaretic effects of the stable dynorphin-A analog E2078 in the human. J Pharmacol Exp Ther 270:342-347
28. Ohno M, Yamamoto T, Ueki S (1992) Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat. Psychopharmacology 106:31-38
29. Pechnick RN, George R, Poland RE (1987) The effects of the systemic administration of n-methylmorphine chloride, a quaternary analogue of morphine that does not cross the blood-brain barrier, on the release of anterior pituitary hormones in the rat. Psychoneuroendocrinology 12:67-71
30. Raynor K, Hong H, Yasuda K, Yu L, Bell GI, Reisine T (1994) Pharmacological characterization of cloned κ, δ, and μ-opioid receptors. Mol Pharmacol 45:330-334
31. Remmers AE, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F (1999) Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. J Pharmacol Exp Ther 288:827-833
32. Rogers AH, Birch PJ, Harrison SM, Palmer E, Manchee GR, Judd DB, Naylor A, Scopes DIC, Hayes AG (1992) GR94839, a κ-opioid agonist with limited access to the central nervous system, has antinociceptive activity. Br J Pharmacol 106:783-789
33. Salas SP, Roblero JS, Lopez LF, Tachibana T, Huidobro-Toro (1992) [N-methyl-Tyrl, N-methyl-Arg7-D-Leu]- Dynorphin A(1-8) ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat. J Pharmacol Exp Ther 262:979-986
34. Shaw JS, Carroll JA, Alcock P, Main BG (1989) ICI204448: a κ-opioid agonist with limited access to the CNS. Br J Pharmacol 96:986-992
35. Simpkins JW, Swager D, Millard WJ (1991) Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist. Neuroendocrinology 54:384-390
36. Specker S, Wananunkul W, Hatsukami D, Nolin K, Hooke L, Kreek MJ, Pentel PR (1998) Effects of dynorphin A (1-13) on opiate withdrawal in humans. Psychopharmacology 137:326-332
37. Yoshino H, Nakazawa T, Arakawa Y, Kaneko T, Tsuchiya Y, Matsunaga M, Araki S, Ikeda M, Yamatsu K, Tachibana S (1990) Synthesis and structure-activity relationships of dynorphin A(1-8) amide. J Med Chem 33:206-212
38. Yu J, Butelman ER, Woods JH, Chait BT, Kreek MJ (1997a) Dynorphin A(1-8) analog, E-2078, is stable in human and rhesus monkey blood. J Pharmacol Exp Ther 280:1147-1151
39. Yu J, Butelman ER, Woods JH, Chait BT, Kreek MJ (1997b) Dynorphin A(1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys. J Pharmacol Exp Ther 282:633-638